Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Svitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, R. Douglas Shytle & Paul R. Sanberg. (2016) Potential new complication in drug therapy development for amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 16:12, pages 1397-1405.
Read now
Read now
Verena C Haringer & Summer B Gibson. (2015) Amyotrophic lateral sclerosis: clinical perspectives. Orphan Drugs: Research and Reviews 5, pages 19-31.
Read now
Read now
Abigail DeLoach, Michael Cozart, Arianna Kiaei & Mahmoud Kiaei. (2015) A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies. Expert Opinion on Drug Discovery 10:10, pages 1099-1118.
Read now
Read now
Magdalena Kuzma-Kozakiewicz & Hubert Kwiecinski. (2011) New therapeutic targets for amyotrophic lateral sclerosis. Expert Opinion on Therapeutic Targets 15:2, pages 127-143.
Read now
Read now
Stefano Zoccolella, Andrea Santamato & Paolo Lamberti. (2009) Current and emerging treatments for amyotrophic lateral sclerosis. Neuropsychiatric Disease and Treatment 5, pages 577-595.
Read now
Read now
Articles from other publishers (44)
Jeremy M Shefner, Antonio Musaro, Shyuan T Ngo, Christian Lunetta, Frederik J Steyn, Richard Robitaille, Mamede De Carvalho, Seward Rutkove, Albert C Ludolph & Luc Dupuis. (2023) Skeletal muscle in amyotrophic lateral sclerosis. Brain 146:11, pages 4425-4436.
Crossref
Crossref
Emilly A. Cortés Mancera, Fabio A. Sinisterra Solis, Francisco R. Romero-Castellanos, Ivan E. Diaz-Meneses & Nora E. Kerik-Rotenberg. (2023) 18F-FDG PET/CT as a molecular biomarker in the diagnosis of amyotrophic lateral sclerosis associated with prostate cancer and progressive supranuclear palsy: A case report. Frontiers in Nuclear Medicine 3.
Crossref
Crossref
Mohd Aizuddin Mohd Lazaldin, Lidawani Lambuk, Suhana Ahmad & Rohimah Mohamud. 2023. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
187
243
.
Abrar Alhindi, Ines Boehm & Helena Chaytow. (2021) Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS). Journal of Anatomy 241:5, pages 1089-1107.
Crossref
Crossref
Shyuan T. Ngo, Hao Wang, Robert D. Henderson, Cyril Bowers & Frederik J. Steyn. (2021) Ghrelin as a treatment for amyotrophic lateral sclerosis. Journal of Neuroendocrinology 33:7.
Crossref
Crossref
Justin Roberto, Kathy L. Poulin, Robin J. Parks & Panayiotis O. Vacratsis. (2021) Label‐free quantitative proteomic analysis of extracellular vesicles released from fibroblasts derived from patients with spinal muscular atrophy. PROTEOMICS 21:13-14.
Crossref
Crossref
Mroj Alassaf & Mary C Halloran. (2021) Pregnancy-associated plasma protein-aa regulates endoplasmic reticulum–mitochondria associations. eLife 10.
Crossref
Crossref
Tomoya Terashima, Shuhei Kobashi, Yasuhiro Watanabe, Mami Nakanishi, Naoto Honda, Miwako Katagi, Natsuko Ohashi & Hideto Kojima. (2020) Enhancing the Therapeutic Efficacy of Bone Marrow-Derived Mononuclear Cells with Growth Factor-Expressing Mesenchymal Stem Cells for ALS in Mice. iScience 23:11, pages 101764.
Crossref
Crossref
Cinzia Volonté, Giovanna Morello, Antonio Gianmaria Spampinato, Susanna Amadio, Savina Apolloni, Velia D’Agata & Sebastiano Cavallaro. (2020) Omics-based exploration and functional validation of neurotrophic factors and histamine as therapeutic targets in ALS. Ageing Research Reviews 62, pages 101121.
Crossref
Crossref
Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, Wolfgang Koenig, Luc Dupuis, Dietrich Rothenbacher & Albert C. Ludolph. (2020) Association of Insulin-like Growth Factor 1 Concentrations with Risk for and Prognosis of Amyotrophic Lateral Sclerosis – Results from the ALS Registry Swabia. Scientific Reports 10:1.
Crossref
Crossref
Elena Abati, Nereo Bresolin, Giacomo Comi & Stefania Corti. (2019) Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis. Molecular Neurobiology 56:10, pages 6703-6715.
Crossref
Crossref
Elisa Lepore, Irene Casola, Gabriella Dobrowolny & Antonio Musarò. (2019) Neuromuscular Junction as an Entity of Nerve-Muscle Communication. Cells 8:8, pages 906.
Crossref
Crossref
Audrey M. G. Ragagnin, Sina Shadfar, Marta Vidal, Md Shafi Jamali & Julie D. Atkin. (2019) Motor Neuron Susceptibility in ALS/FTD. Frontiers in Neuroscience 13.
Crossref
Crossref
Mroj Alassaf, Emily C Daykin, Jaffna Mathiaparanam & Marc A Wolman. (2019) Pregnancy-associated plasma protein-aa supports hair cell survival by regulating mitochondrial function. eLife 8.
Crossref
Crossref
Horacio Uri Saragovi, Alba Galan & Leonard A. Levin. (2019) Neuroprotection: Pro-survival and Anti-neurotoxic Mechanisms as Therapeutic Strategies in Neurodegeneration. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
Klara Valko & Lukasz Ciesla. 2019.
63
117
.
Reema Singh, Priyanka Chaudhary & Ranjana Arya. (2018) Role of IGF-1R in ameliorating apoptosis of GNE deficient cells. Scientific Reports 8:1.
Crossref
Crossref
Yingxiao Ji, Weisong Duan, Yaling Liu, Yakun Liu, Chang Liu, Yuanyuan Li, Di Wen, Zhongyao Li & Chunyan Li. (2018) IGF1 affects macrophage invasion and activation and TNF-α production in the sciatic nerves of female SOD1G93A mice. Neuroscience Letters 668, pages 1-6.
Crossref
Crossref
George Fotakopoulos, Kostas Fountas, Eleni Tsianaka, Polikceni Kotlia, Dimitrios Pachatouridis, Thanos Paschalis & Spyridon Voulgaris. (2018) Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?. Future Science OA 4:2, pages FSO260.
Crossref
Crossref
Vijay Kumar, Asimul Islam, Md. Imtaiyaz Hassan & Faizan Ahmad. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. European Journal of Medicinal Chemistry 121, pages 903-917.
Crossref
Crossref
Ioanna Eleftheriadou, Ioannis Manolaras, Elaine E. Irvine, Michael Dieringer, Antonio Trabalza & Nicholas D. Mazarakis. (2016)
α
CAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice
. Annals of Clinical and Translational Neurology 3:10, pages 752-768.
Crossref
Crossref
Paraskevi N. Koutsoudaki, Florentia Papastefanaki, Antonios Stamatakis, Georgia Kouroupi, Evangelia Xingi, Fotini Stylianopoulou & Rebecca Matsas. (2016) Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury. Glia 64:5, pages 763-779.
Crossref
Crossref
Xiang Yin, Ming Ren, Haizhi Jiang, Shangjin Cui, Shuyu Wang, Hongquan Jiang, Yan Qi, Jing Wang, Xudong Wang, Guangtao Dong, Peter Leeds, De-Maw Chuang & Honglin Feng. (2015) Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model. Molecular and Cellular Neuroscience 68, pages 303-313.
Crossref
Crossref
Michael Jablonski, David S. Miller, Piera Pasinelli & Davide Trotti. (2015) ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis. Brain Research 1607, pages 1-14.
Crossref
Crossref
J. Simon Lunn, Stacey A. Sakowski, Lisa M. McGinley, Crystal Pacut, Thomas G. Hazel, Karl Johe & Eva L. Feldman. (2015) Autocrine Production of IGF-I Increases Stem Cell-Mediated Neuroprotection. Stem Cells 33:5, pages 1480-1489.
Crossref
Crossref
Laura K. Wood & Steven J. Langford. (2014) Motor Neuron Disease: A Chemical Perspective. Journal of Medicinal Chemistry 57:15, pages 6316-6331.
Crossref
Crossref
Li-Kai Tsai, Chien-Lin Chen, Chen-Hung Ting, Sue Lin-Chao, Wuh-Liang Hwu, James C Dodge, Marco A Passini & Seng H Cheng. (2014) Systemic Administration of a Recombinant AAV1 Vector Encoding IGF-1 Improves Disease Manifestations in SMA Mice. Molecular Therapy 22:8, pages 1450-1459.
Crossref
Crossref
Antonio Musarò. (2013)
Understanding
ALS
: new therapeutic approaches
. The FEBS Journal 280:17, pages 4315-4322.
Crossref
Crossref
Chen Benkler, Tali Ben-Zur, Yael Barhum & Daniel Offen. (2013)
Altered astrocytic response to activation in SOD1
G93A
mice and its implications on amyotrophic lateral sclerosis pathogenesis
. Glia 61:3, pages 312-326.
Crossref
Crossref
D. Michal Freedman, Rochelle E. Curtis, Sarah E. Daugherty, James J. Goedert, Ralph W. Kuncl & Margaret A. Tucker. (2012) The association between cancer and amyotrophic lateral sclerosis. Cancer Causes & Control 24:1, pages 55-60.
Crossref
Crossref
Stacey A Sakowski, J Simon Lunn, Angela S Busta, Sang Su Oh, Grettel Zamora-Berridi, Madeline Palmer, Andrew A Rosenberg, Stephen G Philip, James J Dowling & Eva L Feldman. (2012) Neuromuscular effects of G93A-SOD1 expression in zebrafish. Molecular Neurodegeneration 7:1.
Crossref
Crossref
Stacey A. Sakowski & Eva L. Feldman. (2012) Insulin-Like Growth Factors in the Peripheral Nervous System. Endocrinology and Metabolism Clinics of North America 41:2, pages 375-393.
Crossref
Crossref
Nicholas M. Boulis, Thais Federici, Jonathan D. Glass, J. Simon Lunn, Stacey A. Sakowski & Eva L. Feldman. (2011) Translational stem cell therapy for amyotrophic lateral sclerosis. Nature Reviews Neurology 8:3, pages 172-176.
Crossref
Crossref
Gwenn A. Garden & Albert R. La Spada. (2012) Intercellular (Mis)communication in Neurodegenerative Disease. Neuron 73:5, pages 886-901.
Crossref
Crossref
Adam D. Rubin, Norman D. Hogikyan, Alex Oh & Eva L. Feldman. (2012) Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy. The Laryngoscope 122:2, pages 349-355.
Crossref
Crossref
Dan Krakora, Corey Macrander & Masatoshi Suzuki. (2012) Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis. Neurology Research International 2012, pages 1-8.
Crossref
Crossref
José Fernando Maya-Vetencourt, Laura Baroncelli, Alessandro Viegi, Ettore Tiraboschi, Eero Castren, Antonino Cattaneo & Lamberto Maffei. (2012) IGF-1 Restores Visual Cortex Plasticity in Adult Life by Reducing Local GABA Levels. Neural Plasticity 2012, pages 1-10.
Crossref
Crossref
Cinzia Volonté, Savina Apolloni, Maria Teresa Carrì & Nadia D'Ambrosi. (2011) ALS: Focus on purinergic signalling. Pharmacology & Therapeutics 132:1, pages 111-122.
Crossref
Crossref
Michal Dadon-Nachum, Ofer Sadan, Itay Srugo, Eldad Melamed & Daniel Offen. (2011) Differentiated Mesenchymal Stem Cells for Sciatic Nerve Injury. Stem Cell Reviews and Reports 7:3, pages 664-671.
Crossref
Crossref
Kathie Clarke & Todd Levine. (2011) Clinical Recognition and Management of Amyotrophic Lateral Sclerosis. Journal of Neuroscience Nursing 43:4, pages 205-214.
Crossref
Crossref
J Simon Lunn, Stacey A Sakowski, Thais Federici, Jonathan D Glass, Nicholas M Boulis & Eva L Feldman. (2011) Stem cell technology for the study and treatment of motor neuron diseases. Regenerative Medicine 6:2, pages 201-213.
Crossref
Crossref
Michal Dadon-Nachum, Eldad Melamed & Daniel Offen. (2010) The “Dying-Back” Phenomenon of Motor Neurons in ALS. Journal of Molecular Neuroscience 43:3, pages 470-477.
Crossref
Crossref
Adam D. Schuyler, Heather A. Carlson & Eva L. Feldman. (2011) Computational methods for identifying a layered allosteric regulatory mechanism for ALS-causing mutations of Cu-Zn superoxide dismutase 1. Proteins: Structure, Function, and Bioinformatics 79:2, pages 417-427.
Crossref
Crossref
Akhlaq A. FarooquiAkhlaq A. Farooqui. 2010. Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases. Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
325
382
.